profile icon
Ms

Tina Soulis

Honorary
Florey Department of Neuroscience and Mental Health
diabetes
life sciences & biomedicine
renal and urogenital
autoimmune disease
science & technology
kidney disease
metabolic and endocrine
nitric-oxide
glomerular-disease
Tina Soulis's Profile Picture
Ms

Tina Soulis

 
Division
Medicine, Dentistry and Health Sciences
Tina Soulis's Profile Picture
Ms

Tina Soulis

 
Print
Tina's  Short Profile
 

Find out more about Tina Soulis' experience

Tina Soulis' highlights

Scholarly Works

Displaying the 2 most recent scholarly works from 2 for Tina Soulis.

Scholarly works icon

Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy

DJ Kelly, RE Gilbert, AJ Cox, T Soulis, GT Jerums, ME Cooper

Journal article  |  2001  |  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Profibrotic cytokines and the formation of advanced-glycation end products (AGE) have both been implicated in the pathogenesis of ..

Scholarly works icon

Renoprotective effects of a novel inhibitor of advanced glycation

JM Forbes, T Soulis, V Thallas, S Panagiotopoulos, DM Long, S Vasan, D Wagle, G Jerums, ME Cooper

Journal article  |  2001  |  DIABETOLOGIA

AIMS/HYPOTHESIS: ALT-946, an inhibitor of advanced glycation with a minimal inhibitory effect on nitric oxide synthase, was compar..

2

Scholarly Works

News

Displaying the 1 most recent news article from 1 for Tina Soulis.

News icon

COVID vaccines for 5 to 11 year olds are inching closer. Here's what we know so far

Vasso Apostolopoulos, Athina (Tina) Soulis, Jack Feehan, Maja Husaric

Australian children aged five to 11 could begin receiving the Pfizer vaccine by the end of November, with the nation’s regulator currently ..

October 28, 2021
conversation Article

1

News Articles

Credentials

Positions

Honorary

Florey Department of Neuroscience and Mental Health